Our plain-English summary of Pericardial Mesothelioma in a Dog: The Feasibility of Ultrasonography in Monitoring Tumor Progression, by R. Nabeta, Y. Nakagawa, S. Chiba, et al (Frontiers in Veterinary Science, 2019).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Authors: R. Nabeta, Y. Nakagawa, S. Chiba, H. Xiantao, T. Usui, K. Suzuki, T. Furuya, R. Fukushima, T. Uchide
- Journal: Frontiers in Veterinary Science
- Published: 2019;6:121
- Type of article: Case report
- Cited by: 5 articles, as counted by NIH iCite
- Read it: PubMed · Publisher · Free full text
Abstract
A 6-year-old neutered male Yorkshire Terrier presented with recurrent pericardial effusion. Although clinical examinations including computed tomography were inconclusive, an exploratory thoracotomy revealed multiple small nodules and plaques on the inner surface of the pericardial sac (Day 1). A subtotal pericardiectomy was performed to prevent cardiac tamponade due to the increasing pericardial effusion, and the resected section of the pericardium was histopathologically diagnosed with mesothelioma. After surgery, chemotherapy with intrathoracic carboplatin was commenced. During the course of the treatment, a detailed follow-up ultrasonographic scan was performed to detect early lesions disseminated on the pleura, originating from the primary pericardial mesothelioma. On Day 101, the minute pleural nodules, which were disseminated lesions as predicted, were successfully imaged by ultrasonography. As the clinical stage advanced, the nodules were observed to gradually increase in size and number, implying tumor progression. These observations highlight the feasibility of ultrasonography in detecting minute disseminated lesions at an early stage, monitoring tumor progression, and thereby, predicting the prognosis of canine pericardial mesothelioma.
In plain English
This case report described one dog, a neutered male 6-year-old Yorkshire Terrier, referred to a veterinary teaching hospital at the Tokyo University of Agriculture and Technology with recurrent fluid around the heart (pericardial effusion). Blood tests, ultrasonography and CT scanning did not find the cause. During surgery on Day 1, most of the sac around the heart was removed. Small white nodules and plaques were seen on its inner surface, and tissue examination confirmed mesothelioma, diagnosed as primary pericardial mesothelioma. The dog then received chemotherapy into the chest with carboplatin and gemcitabine. Follow-up chest ultrasound showed fluid around the lungs again on Day 38. On Day 101 it showed nodules 1.0–1.3 mm in size on the lining of the chest wall (parietal pleura), and a biopsy confirmed these as spread of the tumor. The nodules grew in size and number even while the fluid temporarily cleared. The dog died of progressive breathing difficulty seven and a half months after surgery. The authors concluded that the case highlights the feasibility of ultrasonography for assessing tumor progression. The article does not discuss asbestos or what caused the tumor.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: case report (single dog, written retrospectively)
- Who was studied: One neutered male 6-year-old Yorkshire Terrier weighing 1.76 kg, referred to the Animal Medical Center at the Tokyo University of Agriculture and Technology, Japan, with recurrent pericardial effusion
- Exposure: No exposure (asbestos or other) was studied or reported. The article does not discuss the cause of the tumor.
- Main results:
- Before surgery, ultrasonography and CT showed fluid but no confirmatory evidence of malignancy
- At surgery (Day 1), multiple white nodules and plaques were found on the inner surface of the pericardial sac, while the outer surface and the serous membrane in the pleural cavity appeared intact. Histopathology confirmed mesothelioma, diagnosed as primary pericardial mesothelioma.
- Follow-up ultrasonography found recurrent pleural effusion on Day 38 and multiple nodules 1.0–1.3 mm in size on the parietal pleura on Day 101
- The nodules increased in size and number despite intermittent resolution of the pleural effusion with chemotherapy. They later coalesced into pleural thickening and were also found on the diaphragm. A biopsy confirmed them as disseminated pericardial mesothelioma.
- Treatment was thoracentesis plus intrathoracic carboplatin (100 mg/m2) and gemcitabine (2 mg/kg weekly) for 6 months. The dog died of progressive respiratory distress seven and a half months after surgery, and no autopsy was performed.
- The amount of pleural effusion did not correlate with tumor progression seen on ultrasonography
- The authors' conclusion: The authors concluded that the report highlights the feasibility of using ultrasonography to assess tumor progression in canine pericardial mesothelioma. They described non-invasive ultrasonography as a modality that could be promising for evaluating tumor progression and predicting prognosis.
- Limitations the authors state:
- Cytology of the pleural fluid, including immunocytochemistry to tell reactive changes from cancer, was not performed. Early microscopic pleural lesions at the time of surgery therefore could not be excluded.
- Without pleural effusion, the early minute pleural lesions could not be detected by ultrasonography
Topics
Medical terms in this study, explained in our Lexicon: Pericardial Mesothelioma, Pericardial Effusion, Thoracotomy, Pericardial, Pericardiectomy, Cardiac Tamponade, Pericardium, Mesothelioma.
Related studies
- The Correlation of Serum Mesothelin Level With Pleural Thickness in Malignant Pleural Mesothelioma Makes it a Valuable Tool for Monitoring Tumor Progression — V. Fontana, A. Vigani, et al. (2019)
- The feasibility of contrast enhanced ultrasonography (CEUS) in the diagnosis of non-cardiac thoracic disorders of dogs and cats — N. Linta, M. Baron Toaldo, et al. (2017)
- Chemosensitivity of three patient-derived primary cultures of canine pericardial mesothelioma by single-agent and combination treatment — R. Nabeta, A. Kanaya, et al. (2023)
- Feasibility of identifying high-risk occupations through tumor registries — M.D. Whorton, J. Schulman, et al. (1983)
- Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data — T. Kutuk, H. Appel, et al. (2022)
- Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression — H. Yang, L. Pellegrini, et al. (2015)
Browse more research in Frontiers in Veterinary Science, or return to medical research.
How to cite it
Cite the study
R. Nabeta, Y. Nakagawa, S. Chiba, H. Xiantao, T. Usui, K. Suzuki, et al. Pericardial Mesothelioma in a Dog: The Feasibility of Ultrasonography in Monitoring Tumor Progression. Frontiers in Veterinary Science 2019;6:121. doi:10.3389/fvets.2019.00121. PMID: 31058175.
Cite our summary
“Pericardial Mesothelioma in a Dog: The Feasibility of Ultrasonography in Monitoring Tumor Progression.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/pericardial-mesothelioma-in-a-dog-the-feasibility-of-ultrasonography.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.